"This agreement between Vancive Medical Technologies and DUKAL Corp. brings together Vancive’s unique technologies and know-how with DUKAL’s specialized sales team"
CHICAGO--(BUSINESS WIRE)--Vancive Medical Technologies™ and DUKAL Corporation today announced an agreement for the distribution of the Vancive BeneHold™ Absorbent Wound Dressing range in the United States and Canada. The BeneHold range includes the Thin Absorbent Wound Dressing, the Standard Hydrocolloid Dressing and the Bordered Hydrocolloid Dressing with Odor Control.
“This agreement between Vancive Medical Technologies and DUKAL Corp. brings together Vancive’s unique technologies and know-how with DUKAL’s specialized sales team,” said Howard Kelly, president and general manager of Vancive. “DUKAL’s products are already used in traditional wound and skin care, and by adding the BeneHold Absorbent Wound Dressing range, they significantly broaden the continuum of care within their product offering.”
The BeneHold Absorbent Wound Dressings manage lightly to moderately exuding chronic and acute wounds. Products in the BeneHold Absorbent Wound Dressing portfolio are constructed of a self-adherent wound contact layer and a smooth, water-resistant polyurethane top film that acts as a barrier to external contaminants and bacteria. The dressings exhibit superior fluid handling capacity, yet are thinner and more conformable to enhance patient comfort.
The Thin Absorbent Dressings are based on Vancive’s proprietary technology, TASA™ (Thin Absorbent Skin Adhesive™). At only 0.1mm in thickness, TASA has the capacity to manage fluid in excess of traditional thin hydrocolloids. Furthermore, the dressings are transparent and allow for site visibility up to 7 days. The Bordered Hydrocolloid Dressing with Odor Control is formulated with organic, non-cytotoxic cyclodextrins that capture odor molecules to help increase patient confidence.
“Not only does this new agreement between DUKAL Corp. and Vancive Medical Technologies benefit the two companies through the use of one cohesive operational system and go-to-market strategy, it also extends those efficiencies throughout the healthcare supply system,” said DUKAL President Gerry LoDuca. “This new alliance means our customers can now secure an even greater breadth of products through a single provider.”
BeneHold™ and TASA™ (Thin Absorbent Skin Adhesive™) are trademarks of Avery Dennison Corporation.
About Vancive Medical Technologies
Vancive Medical Technologies makes inspired advances that lead to intelligent results. The business uses the most advanced adhesive and material technologies to create products that make healthcare easier for everyone. Vancive Medical Technologies is an Avery Dennison business headquartered in Chicago, Illinois. To learn more about Vancive Medical Technologies, visit www.vancive.averydennison.com.
About Avery Dennison
Avery Dennison (NYSE:AVY) is a global leader in labeling and packaging materials and solutions. The company’s applications and technologies are an integral part of products used in every major market and industry. With operations in more than 50 countries and 26,000 employees worldwide, Avery Dennison serves customers with insights and innovations that help make brands more inspiring and the world more intelligent. Headquartered in Glendale, California, the company reported sales from continuing operations of $6.1 billion in 2013. Learn more at www.averydennison.com.
About Dukal Corporation
Established in 1991, DUKAL Corporation (www.dukal.com) is a privately held supplier of medical, health and wellness products. The company employs many strategic manufacturing partnerships focused on high quality to provide best in class products and supply chain solutions to its customers. DUKAL Corp. products are used in hospitals, physician practices, home care agencies, nursing homes and dental offices across the U.S. and Europe, as well as by veterinary practices and animal hospitals, emergency medical services and public safety providers, clinical laboratories and industrial sites.